Modular Medical Inc MODD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MODD is a good fit for your portfolio.
News
-
Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30
-
Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30
-
Modular Medical Announces Steve Gemmell as New Vice President of Engineering
-
Registration Is Now Open for Tribe Public's Webinar Event "Revolutionizing Diabetes Care" Featuring Modular Medical CEO on Wednesday, March 6, 2024
Trading Information
- Previous Close Price
- $1.56
- Day Range
- $1.53–1.60
- 52-Week Range
- $0.84–2.22
- Bid/Ask
- $1.53 / $1.61
- Market Cap
- $47.72 Mil
- Volume/Avg
- 47,128 / 127,372
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of an insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. The company's product's seeks to serve both the type 1 and the rapidly growing especially in terms of device adoption, type 2 diabetes markets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 38
- Website
- https://www.modular-medical.com
Valuation
Metric
|
MODD
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 8.53 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
MODD
|
---|---|
Quick Ratio | 1.42 |
Current Ratio | 1.63 |
Interest Coverage | — |
Quick Ratio
MODD
Profitability
Metric
|
MODD
|
---|---|
Return on Assets (Normalized) | −159.77% |
Return on Equity (Normalized) | −201.29% |
Return on Invested Capital (Normalized) | −174.07% |
Return on Assets
MODD
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Wtdxwtk | Gnlpf | $181.3 Bil | |
SYK
| Stryker Corp | Dbrdbhgnv | Jkpg | $125.8 Bil | |
BSX
| Boston Scientific Corp | Yqcxfkwj | Nzbzkl | $110.8 Bil | |
MDT
| Medtronic PLC | Rlzztjk | Xnvcjzl | $106.7 Bil | |
EW
| Edwards Lifesciences Corp | Ccjxpfynfg | Zmktcq | $52.7 Bil | |
DXCM
| DexCom Inc | Ykntklsl | Fydf | $51.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Kbcxmxkg | Rdkjrc | $25.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Cgmzrmcdb | Yvj | $23.8 Bil | |
ALGN
| Align Technology Inc | Fyhksqlty | Dxcyndy | $19.9 Bil | |
PODD
| Insulet Corp | Yqfvnxrzk | Yddfprr | $12.7 Bil |